Literature DB >> 21052659

PET/CT in paediatric oncology: clinical usefulness and dosimetric concerns.

Giovanni Lucignani1, Diego De Palma.   

Abstract

Mesh：

Year:  2011        PMID： 21052659     DOI： 10.1007/s00259-010-1661-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  15 in total

Review 1.  Dose reduction in pediatric hybrid and planar imaging.

Authors:  M J Gelfand
Journal:  Q J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 2.346

2.  Clinical impact of integrating positron emission tomography during surgery in 85 children with brain tumors.

Authors:  Benoit J M Pirotte; Alphonse Lubansu; Nicolas Massager; David Wikler; Patrick Van Bogaert; Marc Levivier; Jacques Brotchi; Serge Goldman
Journal:  J Neurosurg Pediatr       Date:  2010-05       Impact factor: 2.375

3.  Clinical interest of integrating positron emission tomography imaging in the workup of 55 children with incidentally diagnosed brain lesions.

Authors:  Benoit J M Pirotte; Alphonse Lubansu; Nicolas Massager; David Wikler; Patrick Van Bogaert; Marc Levivier; Jacques Brotchi; Serge Goldman
Journal:  J Neurosurg Pediatr       Date:  2010-05       Impact factor: 2.375

4.  Evaluation of focal cortical dysplasia and mixed neuronal and glial tumors in pediatric epilepsy patients using 18F-FDG and 11C-methionine pet.

Authors:  Ji Hoon Phi; Jin Chul Paeng; Hyo Sang Lee; Kyu-Chang Wang; Byung-Kyu Cho; Ji-Yeoun Lee; Sung-Hye Park; Joongyub Lee; Dong Soo Lee; Seung-Ki Kim
Journal:  J Nucl Med       Date:  2010-04-15       Impact factor: 10.057

5.  Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.

Authors:  B H Kushner; H W Yeung; S M Larson; K Kramer; N K Cheung
Journal:  J Clin Oncol       Date:  2001-07-15       Impact factor: 44.544

Review 6.  FDG-PET/CT in pediatric solid tumors.

Authors:  C Franzius
Journal:  Q J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 2.346

Review 7.  Modern nuclear medicine evaluation of neuroblastoma.

Authors:  T Pflüger; I Schmid; E Coppenrath; M Weiss
Journal:  Q J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 2.346

8.  Role of PET/CT in malignant pediatric lymphoma.

Authors:  Raef Riad; Walid Omar; Magdy Kotb; Magdy Hafez; Iman Sidhom; Manal Zamzam; Iman Zaky; Hussein Abdel-Dayem
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-15       Impact factor: 9.236

9.  Diagnostic value of PET/CT for the staging and restaging of pediatric tumors.

Authors:  Margit Kleis; Heike Daldrup-Link; Katherine Matthay; Robert Goldsby; Ying Lu; Tibor Schuster; Carole Schreck; Philip W Chu; Randall A Hawkins; Benjamin L Franc
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-22       Impact factor: 9.236

10.  [11C]-L-methionine positron emission tomography in the management of children and young adults with brain tumors.

Authors:  Norbert Galldiks; Lutz W Kracht; Frank Berthold; Hrvoje Miletic; Johannes C Klein; Karl Herholz; Andreas H Jacobs; Wolf-Dieter Heiss
Journal:  J Neurooncol       Date:  2009-07-04       Impact factor: 4.130
View more
  4 in total

1.  PET/MRI and the revolution of the third eye.

Authors:  Luigi Mansi; Andrea Ciarmiello; Vincenzo Cuccurullo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10       Impact factor: 9.236

Review 2.  123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.

Authors:  Gitta Bleeker; Godelieve A M Tytgat; Judit A Adam; Huib N Caron; Leontien C M Kremer; Lotty Hooft; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2015-09-29

3.  Intravenous ultrasound contrast agents versus other imaging methods in pediatric patients with neoplastic diseases - a comparison.

Authors:  Maciej Piskunowicz; Wojciech Kosiak; Tomasz Batko; Elżbieta Adamkiewicz-Drożyńska; Arkadiusz Szarmach
Journal:  J Ultrason       Date:  2013-12-30

4.  Lactate and choline metabolites detected in vitro by nuclear magnetic resonance spectroscopy are potential metabolic biomarkers for PI3K inhibition in pediatric glioblastoma.

Authors:  Nada M S Al-Saffar; Lynley V Marshall; L Elizabeth Jackson; Geetha Balarajah; Thomas R Eykyn; Alice Agliano; Paul A Clarke; Chris Jones; Paul Workman; Andrew D J Pearson; Martin O Leach
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.